IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 fourth quarter and full year financial results for Monday, February 3, 2025 ...
Hosted on MSN1mon
Global Expansion to Support IDEXX Stock Despite Macroeconomic IssuesIDEXX largely provides advanced diagnostic capabilities that meet veterinarians ... and Web PACS (picture archiving and communication system imaging software) continue to be in high demand ...
Hosted on MSN4d
IDEXX Stock Suffers Due to Macroeconomic Issues and FX WoesIDEXX’s IDXX business continues to be dampened by currency impacts and uncertain macroeconomic conditions. The stock carries ...
IDEXX Laboratories, Inc. (IDXX), valued at ... and blood gas analyzers for the human point-of-care medical diagnostics market. It is expected to announce its fiscal Q4 earnings results before ...
Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks An announcement from Idexx ...
Headquartered in Westbrook, ME, IDEXX Laboratories ... and blood gas analyzers for the human point-of-care medical diagnostics market. IDXX is a Zacks Rank #3 (Hold) stock, with a Growth Style ...
About IDEXX Laboratories, Inc. IDEXX is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of ...
IDEXX Laboratories, Inc. (NASDAQ:IDXX), a leader in veterinary diagnostics and software with a market capitalization of $35 billion, continues to navigate a complex market environment characterized by ...
About IDEXX Laboratories IDEXX is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback